ANDROGEN DEPRIVATION THERAPY IN PATIENTS WITH ADVANCED PROSTATE CANCER AND TYPE 2 DIABETES IMPAIRS GLUCOSE AND LIPID METABOLISM

被引：0
|
作者：
Haider, A.
Yassin, A. [1 ,2 ]
Shabsigh, R. [3 ,4 ]
Saad, F. [1 ,5 ]
机构：
[1] Gulf Med Univ, Sch Med, Ajman, U Arab Emirates
[2] Segeberger Kliniken Norderstedt, Inst Urol & Androl, Hamburg, Germany
[3] Columbia Univ, New York, NY USA
[4] Maimonides Hosp, New York, NY USA
[5] Bayer Schering Pharma, Sci Affairs Mens Healthcare, Berlin, Germany
来源：
JOURNAL OF MENS HEALTH | 2009年 / 6卷 / 03期
关键词：
D O I：
10.1016/j.jomh.2009.08.062
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
64
引用
收藏
页码：243 / 243
页数：1
相关论文
共 50 条
  • [21] Depression and androgen-deprivation therapy for advanced prostate cancer
    Savard, J.
    Simard, S.
    Hervouet, S.
    Ivers, H.
    Rioux, D.
    PSYCHO-ONCOLOGY, 2007, 16 (09) : S151 - S152
  • [22] Androgen deprivation for advanced prostate cancer
    Heidenreich, A.
    Pfister, D.
    Ohlmann, C. H.
    Engelmann, U. H.
    UROLOGE, 2008, 47 (03): : 270 - +
  • [23] Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate
    Ross, Robert W.
    Xie, Wanling
    Regan, Meredith M.
    Pomerantz, Mark
    Nakabayashi, Mari
    Daskivich, Timothy J.
    Sartor, Oliver
    Taplin, Mary-Ellen
    Kantoff, Philip W.
    Oh, William K.
    CANCER, 2008, 112 (06) : 1247 - 1253
  • [24] INFLUENCE OF DIFFERENT MODALITIES OF ANDROGEN DEPRIVATION THERAPY ON LIPID AND GLUCOSE METABOLISM AND FAT ACCUMULATION IN PATIENTS WITH PROSTATE CANCER: DEGARELIX VS LEUPROLIDE PLUS BICALUTAMIDE
    Sawazaki, Harutake
    Araki, Daiji
    JOURNAL OF UROLOGY, 2019, 201 (04): : E497 - E497
  • [25] Androgen deprivation therapy and statin therapy in prostate cancer patients
    Lai, Kin Chung
    Turknett, Toiya
    Singh, Parminder
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [26] Reversibility of androgen deprivation therapy in patients with prostate cancer
    Fridmans, A
    Chertin, B
    Koulikov, D
    Lindenberg, T
    Gelber, H
    Leiter, C
    Farkas, A
    Spitz, IM
    JOURNAL OF UROLOGY, 2005, 173 (03): : 784 - 789
  • [27] PREFERRED TREATMENT FREQUENCY IN PATIENTS RECEIVING ANDROGEN DEPRIVATION THERAPY FOR ADVANCED PROSTATE CANCER
    Fode, Mikkel
    Nielsen, Torben
    Andersen, Jesper R.
    Jakobsen, Henrik
    Sonksen, Jens
    JOURNAL OF UROLOGY, 2013, 189 (04): : E296 - E297
  • [28] The impact of celecoxib on outcomes in advanced prostate cancer patients undergoing androgen deprivation therapy
    Etheridge, Tyler
    Liou, Jinning
    Downs, Tracy M.
    Abel, E. Jason
    Richards, Kyle A.
    Jarrard, David F.
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2018, 6 (03): : 123 - 132
  • [29] Preferred treatment frequency in patients receiving androgen deprivation therapy for advanced prostate cancer
    Fode, Mikkel
    Nielsen, Torben K.
    Al-Hamadani, Muhammad
    Andersen, Jesper R.
    Jakobsen, Henrik
    Sonksen, Jens
    SCANDINAVIAN JOURNAL OF UROLOGY, 2013, 47 : 28 - 28
  • [30] Preferred treatment frequency in patients receiving androgen deprivation therapy for advanced prostate cancer
    Fode, Mikkel
    Nielsen, Torben K.
    Al-Hamadani, Muhammad
    Andersen, Jesper R.
    Jakobsen, Henrik
    Sonksen, Jens
    SCANDINAVIAN JOURNAL OF UROLOGY, 2014, 48 (02) : 183 - 188
12345